PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97534510 |
Filing Date: 08/04/2022 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | RectiBiom |
*STANDARD CHARACTERS | YES |
USPTO-GENERATED IMAGE | YES |
LITERAL ELEMENT | RectiBiom |
*MARK STATEMENT | The mark consists of standard characters, without claim to any particular font style, size, or color. |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Biom Pharmaceutical Corporation |
*MAILING ADDRESS | 2203 industrial blvd |
*CITY | sarasota |
*STATE (Required for U.S. applicants) |
Florida |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
34234 |
PHONE | 505-220-4145 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.biompharma.com |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Nevada |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 003 |
*IDENTIFICATION | Astringents for cosmetic purposes |
*FILING BASIS | SECTION 1(a) |
FIRST USE ANYWHERE DATE | At least as early as 06/12/2020 |
FIRST USE IN COMMERCE DATE | At least as early as 06/18/2020 |
SPECIMEN FILE NAME(S) | |
ORIGINAL PDF FILE | SPE0-26033027a0d2700a8f05 b0d3f5a85e-20220804112629 860307_._Specimen.pdf |
CONVERTED PDF FILE(S) (1 page) |
\\TICRS\EXPORT18\IMAGEOUT 18\975\345\97534510\xml1\ FTK0003.JPG |
SPECIMEN DESCRIPTION | A photograph of the labeled product which is commercially marketed |
WEBPAGE URL | None Provided |
WEBPAGE DATE OF ACCESS | None Provided |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
The wording rectibiom has no meaning in a foreign language. |
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
CORRESPONDENCE INFORMATION | |
NAME | Biom Pharmaceutical Corporation |
DOCKET/REFERENCE NUMBER | 08/2022 Biom |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | bbobban@gmail.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | bobban@biompharma.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Bob Subhadra/ |
* SIGNATORY'S NAME | Bobban Subhadra |
* SIGNATORY'S POSITION | President |
SIGNATORY'S PHONE NUMBER | 505-220-4145 |
* DATE SIGNED | 08/04/2022 |
SIGNATURE METHOD | Signed directly within the form |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97534510 |
Filing Date: 08/04/2022 |
The applicant's current Correspondence Information: |
Biom Pharmaceutical Corporation |
PRIMARY EMAIL FOR CORRESPONDENCE: bbobban@gmail.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): bobban@biompharma.com The docket/reference number is 08/2022 Biom. Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|